Insomnia in hospitalized psychiatric patients: prevalence and associated factors

Talih, Farid; Ajaltouni, Jean; Ghandour, Hiba; Abu-Mohammad, Ahmad; Kobeissy, Firas

doi:10.2147/ndt.s160742

Cited by 17 publications

(15 citation statements)

References 63 publications

(63 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During the COVID-19 outbreak, physical and psychological symptoms are common in the general population [ 98 ]. The severity of insomnia was related to symptoms of depression and anxiety [ 99 ]. Research conducted during the initial stage of COVID-19 had highlighted its impact on mental health, with many people showing anxiety and depression [ 100 , 101 ], facing the risk of post-traumatic stress disorder [ 102 ].…”

Section: The ‘Three Syndromes and Six Chinese Patent Medicines’ Projectmentioning

confidence: 99%

The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

Duan

Zhang

et al. 2021

Chin Med

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), first broke out in Wuhan, China, in 2019. SARS-CoV-2 develops many types of mutations (such as B.1.1.7), making diagnosis and treatment challenging. Although we now have a preliminary understanding of COVID-19, including pathological changes, clinical manifestations, and treatment measures, we also face new difficulties. The biggest problem is that most COVID-19 patients might face sequelae (e.g., fatigue, sleep disturbance, pulmonary fibrosis) during the recovery phase. We aimed to test six Chinese patent medicines to treat three major abnormal symptoms in COVID-19 patients during the recovery phase, including cardiopulmonary function, sleep disturbance, and digestive function. We launched the “three syndromes and six Chinese patent medicines” randomized, double-blind, placebo-controlled, multicenter clinical trial on April 10, 2020. The results showed that Jinshuibao tablets and Shengmaiyin oral liquid significantly improved the cardiopulmonary function of recovering COVID-19 patients. Shumian capsules, but not Xiaoyao capsules, significantly improved patients’ sleep disorders. This might be because the indication of Xiaoyao capsules is liver qi stagnation rather than psychological or emotional problems. Xiangsha Liujun pills and Ludangshen oral liquid significantly improved digestive function. Our research provides a guideline for treating COVID-19 sequelae in patients during the recovery period based on high-quality evidence.

show abstract

Section: The ‘Three Syndromes and Six Chinese Patent Medicines’ Projectmentioning

confidence: 99%

The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

Duan

Zhang

et al. 2021

Chin Med

View full text Add to dashboard Cite

show abstract

“…Chronic insomnia occurs at least three nights per week for at least three months, despite adequate opportunity for sleep. 8,9 Various risk factors for insomnia have been identified including gender, age, depression, regular use of sedative-hypnotic drugs, the onset of menses, previous insomnia complaints, snoring, low levels of physical activity, comorbidities and nocturnal micturition. 4,[9][10][11][12][13] Hospitalisation can often result in a period of acute sleep deprivation.…”

Section: Application To Patient Carementioning

confidence: 99%

“…8,9 Various risk factors for insomnia have been identified including gender, age, depression, regular use of sedative-hypnotic drugs, the onset of menses, previous insomnia complaints, snoring, low levels of physical activity, comorbidities and nocturnal micturition. 4,[9][10][11][12][13] Hospitalisation can often result in a period of acute sleep deprivation. 10 Multiple factors have been found to interfere with inpatient sleep including patient-related factors such as pre-existing anxiety, schizophrenia and depression, illness-related factors such as pain, hyperarousal, whole-body metabolic rate and circadian deregulation and environmental factors such as noise and lighting.…”

Section: Application To Patient Carementioning

confidence: 99%

“…10 Multiple factors have been found to interfere with inpatient sleep including patient-related factors such as pre-existing anxiety, schizophrenia and depression, illness-related factors such as pain, hyperarousal, whole-body metabolic rate and circadian deregulation and environmental factors such as noise and lighting. 1,4,[7][8][9][14][15][16][17] Several studies have confirmed that hospitalisation can have a major impact on sleep quality and quantity. For example, Talih et al found that 67.4% of hospitalised psychiatric patients had insomnia.…”

Section: Application To Patient Carementioning

confidence: 99%

See 1 more Smart Citation

Incidence of and Factors Associated with New-Onset Insomnia Among Lebanese Hospitalised Patients

Sakr

Hallit

Mattar

2021

Sultan Qaboos Univ Med J

View full text Add to dashboard Cite

Objectives: This study aimed to determine the incidence and post-discharge resolution of new-onset insomnia in hospitalised patients with no previous history of insomnia, as well as to define major correlates of in-hospital insomnia. Methods: This prospective observational study was conducted between November 2019 and January 2020 at a tertiary care centre in Lebanon. All hospitalised patients >18 years of age with no history of insomnia were screened for new-onset insomnia using the Insomnia Severity Index (ISI) scale. Subsequently, patients were re-assessed two weeks after discharge to determine insomnia resolution. Results: A total of 75 patients were included in the study. Of these, nine (12%) had no insomnia, 34 (45.3%) had subthreshold insomnia, 22 (29.3%) had moderate insomnia and 10 (13.3%) had severe insomnia. The mean ISI score was 14.95 ± 6.05, with 88% of patients having ISI scores of >7 (95% confidence interval: 0.822–0.965). The frequency of new-onset insomnia was significantly higher among patients who shared a room compared to those in single-bed rooms (95.7% versus 75%; P = 0.011). Other factors were not found to be associated with new-onset insomnia, including the administration of medications known to cause insomnia, in-hospital sedative use, overnight oxygen, cardiac monitoring and self-reported nocturnal toilet use. Overall, insomnia resolution occurred in 78.7% of patients two weeks after discharge. Conclusion: There was a high incidence of acute new-onset insomnia among hospitalised patients at a tertiary centre in Lebanon. Additional research is recommended to further examine inhospital sleep disturbance factors and to seek convenient solutions to limit insomnia. Keywords: Sleep Wake Disorders; Insomnia; Hospitalization; Incidence; Risk Factors; Lebanon.

show abstract

“…Sleep, which is essential for proper physiological functioning and healing, is often interrupted in hospital settings. Prevalence rates of poor sleep in hospitalized patients range from 47-67%, depending on both the care population and setting [1,2]. For example, an estimated 50% of all medical inpatients report difficulty sleeping through the night [3] and sleep on average an hour and a half less than while they are at home [4].…”

Section: Introductionmentioning

confidence: 99%

Sleepless in the hospital: A systematic review of non-pharmacological sleep interventions

Miller

Renn

Chu

et al. 2019

General Hospital Psychiatry

View full text Add to dashboard Cite

Objective: Poor sleep is highly prevalent in inpatient medical settings and has been associated with attenuated healing and worsened outcomes following hospitalization. Although nonpharmacological interventions are preferred, little is known about the best way to intervene in hospital settings. Method: A systematic review of published literature examining nonpharmacological sleep interventions among inpatients in Embase, PsycINFO and PubMed in accordance with PRISMA guidelines. Results: Forty-three of the 1,529 originally identified manuscripts met inclusion criteria, encompassing 2,713 hospitalized participants from 18 countries comprised of psychiatric and older adult patients living in hospital settings. Main outcomes were subjective and objective measures of sleep duration, quality, and insomnia. Conclusions: Overall, the review was unable to recommend any specific intervention due to the current state of the literature. The majority of included research was limited in quality due to lack of controls, lack of blinding, and reliance on self-reported outcomes. However, the literature suggests melatonin and CBT-I likely have the most promise to improve sleep in inpatient medical settings. Additionally, environmental modifications, including designated quiet time and ear plugs/eye masks, could be easily adopted in the care environment and may support sleep improvement. More rigorous research in nonpharmacological sleep interventions for hospitalized individuals is required to inform clinical recommendations.

show abstract

Insomnia in hospitalized psychiatric patients: prevalence and associated factors

Cited by 17 publications

References 63 publications

The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

Incidence of and Factors Associated with New-Onset Insomnia Among Lebanese Hospitalised Patients

Sleepless in the hospital: A systematic review of non-pharmacological sleep interventions

Contact Info

Product

Resources

About